REVA Medical has invested heavily in the development of unique and proprietary bioresorbable polymers and medical device designs that can be used for a variety of medical products and applications ranging from cardiovascular stents to trauma care and orthopedics. Currently, REVA is developing the ReZolve™ Bioresorbable Coronary Stent for the treatment of atherosclerosis that will support arterial restoration and remodeling (healing) and then resorb from the body.
Bioresorbable Polymers
REVA Medical scientists working in collaboration with Rutgers University have developed new proprietary bioresorbable materials for a variety of medical applications. One example is ReZorb™, the unique polymer used in the ReZolve Bioresorbable Coronary Stent. REVA Medical can produce polymers featuring a wide range of material characteristics, including tunable resorption times and adaptable physical properties. Therapeutic drugs can be delivered from a thin polymer coating or permeate the polymer within a device. REVA polymers are also radiopaque as a result of binding iodine molecules directly into the polymer backbone. By overcoming the lack of intrinsic radiopacity in other contemporary polymers, these polymers could enable significant improvements in the performance and reliability of products in orthopedics and other vascular fields.
"Slide & Lock" design mechanism
Better by Design
REVA Medical’s proprietary design technology centers on the patented "slide & lock" mechanism that can provide strength and flexibility to a variety of medical devices. This unique design, when utilized in a stent, mechanically slides open and locks into place at varying diameters making it ideal for use in medical devices that utilize bioresorbable polymers. Additionally, the "slide & lock" design minimizes polymer thickness while providing strength similar to a traditional metal stent. When used with metal alloys, it is ideal for ultra-thin and ultra-flexible applications in neurological and peripheral vascular procedures.